JP2017527544A5 - - Google Patents

Download PDF

Info

Publication number
JP2017527544A5
JP2017527544A5 JP2017506827A JP2017506827A JP2017527544A5 JP 2017527544 A5 JP2017527544 A5 JP 2017527544A5 JP 2017506827 A JP2017506827 A JP 2017506827A JP 2017506827 A JP2017506827 A JP 2017506827A JP 2017527544 A5 JP2017527544 A5 JP 2017527544A5
Authority
JP
Japan
Prior art keywords
antigen
antibody
binding fragment
chain variable
variable region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017506827A
Other languages
English (en)
Japanese (ja)
Other versions
JP6670297B2 (ja
JP2017527544A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/044144 external-priority patent/WO2016022883A1/en
Publication of JP2017527544A publication Critical patent/JP2017527544A/ja
Publication of JP2017527544A5 publication Critical patent/JP2017527544A5/ja
Application granted granted Critical
Publication of JP6670297B2 publication Critical patent/JP6670297B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017506827A 2014-08-07 2015-08-07 抗セラミド抗体 Active JP6670297B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462034453P 2014-08-07 2014-08-07
US62/034,453 2014-08-07
PCT/US2015/044144 WO2016022883A1 (en) 2014-08-07 2015-08-07 Anti-ceramide antibodies

Publications (3)

Publication Number Publication Date
JP2017527544A JP2017527544A (ja) 2017-09-21
JP2017527544A5 true JP2017527544A5 (cg-RX-API-DMAC7.html) 2018-09-13
JP6670297B2 JP6670297B2 (ja) 2020-03-18

Family

ID=55264608

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017506827A Active JP6670297B2 (ja) 2014-08-07 2015-08-07 抗セラミド抗体

Country Status (12)

Country Link
US (4) US10450385B2 (cg-RX-API-DMAC7.html)
EP (1) EP3177650B1 (cg-RX-API-DMAC7.html)
JP (1) JP6670297B2 (cg-RX-API-DMAC7.html)
KR (1) KR102296416B1 (cg-RX-API-DMAC7.html)
CN (1) CN107074949B (cg-RX-API-DMAC7.html)
AU (1) AU2015300902B2 (cg-RX-API-DMAC7.html)
CA (1) CA2957415C (cg-RX-API-DMAC7.html)
IL (1) IL250374B (cg-RX-API-DMAC7.html)
MX (1) MX391141B (cg-RX-API-DMAC7.html)
RU (1) RU2717651C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201700787XA (cg-RX-API-DMAC7.html)
WO (1) WO2016022883A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017228474C1 (en) 2016-03-04 2024-03-28 Abmuno Therapeutics Llc Antibodies to TIGIT
JP7264482B2 (ja) * 2016-12-23 2023-04-25 ブルーフィン バイオメディシン, インコーポレイテッド 抗sez6l2抗体および抗体薬物コンジュゲート
US20200362057A1 (en) 2019-05-16 2020-11-19 Snake River Bioscience, Inc. Compositions and methods for the treatment of major depressive disorder
CN113906051B (zh) * 2019-06-06 2025-06-06 北京加科思新药研发有限公司 对cd73具有特异性的结合分子及其用途
US10975169B1 (en) * 2019-09-27 2021-04-13 Memorial Sloan Kettering Cancer Center Methods for treating diabetic retinopathy using anti-ceramide monoclonal antibody 2A2
KR102245082B1 (ko) * 2020-02-14 2021-04-26 단국대학교 천안캠퍼스 산학협력단 치주인대전구세포 표면에 특이적으로 결합하는 두 가지 IgG 타입 단일클론항체 LG43, LG73 및 그의 용도
WO2021188770A1 (en) * 2020-03-18 2021-09-23 Memorial Sloan Kettering Cancer Center Anti-ceramide antibodies
EP4157875A1 (en) 2020-06-02 2023-04-05 Arcus Biosciences, Inc. Antibodies to tigit
KR20230162788A (ko) * 2021-03-16 2023-11-28 메모리얼 슬로안 케터링 캔서 센터 항-세라마이드 항체를 이용한 상처 치유 증진
WO2024226646A2 (en) * 2023-04-25 2024-10-31 Memorial Sloan-Kettering Cancer Center Dlk1 -targeting antibodies and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
JPH02128697A (ja) 1988-11-09 1990-05-17 Hoechst Japan Ltd 抗フコシルセラミドモノクローナル抗体
US7897753B2 (en) * 2002-02-20 2011-03-01 Sirna Therapeutics, Inc. RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA)
RU2310393C1 (ru) 2006-02-16 2007-11-20 ФГУ Научно-исследовательский институт по изучению лепры Федерального агентства по здравоохранению и социальному развитию Российской Федерации Способ прогнозирования обострений лепрозных невропатий у больных лепрой
JP5924863B2 (ja) 2007-05-06 2016-05-25 スローン ケタリング インスティテュート フォア キャンサー リサーチ Gi症候群及び移植片対宿主病を治療及び予防する方法
US9163091B2 (en) 2007-05-30 2015-10-20 Lpath, Inc. Compositions and methods for binding lysophosphatidic acid
US8410251B2 (en) * 2008-06-20 2013-04-02 National University Corporation Okayama University Antibody against calcified globule and use of the same
KR101050829B1 (ko) * 2008-10-02 2011-07-20 서울대학교산학협력단 항 pd-1 항체 또는 항 pd-l1 항체를 포함하는 항암제
US9090679B2 (en) * 2009-04-17 2015-07-28 Immunas Pharma, Inc. Antibodies that specifically bind to A beta oligomers and use thereof
FR2971250A1 (fr) * 2011-02-07 2012-08-10 Univ Nantes Anticorps anti-gb3 utiles dans le traitement des maladies associees a l'angiogenese
KR101256351B1 (ko) 2011-11-22 2013-04-19 김석진 필터 삽입공을 갖는 카메라 후드
RU2631804C2 (ru) * 2012-02-21 2017-09-26 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения или профилактики рака
EP2854850B1 (en) * 2012-05-25 2021-05-26 Sloan Kettering Institute For Cancer Research Compositions for treating or preventing radiation disease and gi syndrome
WO2021188770A1 (en) * 2020-03-18 2021-09-23 Memorial Sloan Kettering Cancer Center Anti-ceramide antibodies

Similar Documents

Publication Publication Date Title
JP2017527544A5 (cg-RX-API-DMAC7.html)
JP2011514150A5 (cg-RX-API-DMAC7.html)
JP2018500014A5 (cg-RX-API-DMAC7.html)
JP2014158469A5 (cg-RX-API-DMAC7.html)
HRP20200767T1 (hr) Humanizirana anti-humana cd19 protutijela i postupci uporabe
JP2017507652A5 (cg-RX-API-DMAC7.html)
JP2016512551A5 (cg-RX-API-DMAC7.html)
JP2018527919A5 (cg-RX-API-DMAC7.html)
RU2016100892A (ru) Антитела против tweakr и их применение
JP2017528476A5 (cg-RX-API-DMAC7.html)
JP2014511179A5 (cg-RX-API-DMAC7.html)
JP2018513149A5 (cg-RX-API-DMAC7.html)
RU2017119543A (ru) Анти-tim3 антитела и способы их применения
JP2016507470A5 (cg-RX-API-DMAC7.html)
HRP20221471T1 (hr) Protutijela anti-fgfr3 i postupci za njihovu uporabu
RU2018129874A (ru) Антитела против фактора свертывания xi
JP2015520758A5 (cg-RX-API-DMAC7.html)
RU2017123549A (ru) Антитела, нацеленные на антиген созревания в-клеток, и способы их применения
JP2019505527A5 (cg-RX-API-DMAC7.html)
JP2015525795A5 (cg-RX-API-DMAC7.html)
RU2016137110A (ru) Антитела к компоненту комплемента с5
JP2014205674A5 (cg-RX-API-DMAC7.html)
JP2019527194A5 (cg-RX-API-DMAC7.html)
JP2016538832A5 (cg-RX-API-DMAC7.html)
RU2011117237A (ru) АНТИТЕЛА ПРОТИВ Notch2 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ